SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001294046-20-000001
Filing Date
2020-03-23
Accepted
2020-03-23 16:43:22
Documents
1
Period of Report
2020-03-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5715
  Complete submission text file 0001294046-20-000001.txt   7329
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
VERMILLION, INC. (Issuer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O SYMMETRY MEDICAL, INC. 3724 N. ST. RD. 15 WARSAW IN 46582
Business Address
Burns James S (Reporting) CIK: 0001294046 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34810 | Film No.: 20735365